Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Browse Title Index


 
Issue Title
 
Vol 7, No 2 (2014) MANAGEMENT OF MAGNESIUM DEFICIENCY IN PREGNANT WOMEN: PHARMACOEPIDEMIOLOGIC STUDY Abstract   PDF (Rus)
D. V. Blinov, U. V. Zimovina, E. M. Dzhobava
 
Vol 9, No 1 (2016) MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 Abstract   PDF (Rus)
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
 
Vol 11, No 1 (2018) Medical care of ambulatory patients and its assessment: a review of international experience Abstract   PDF (Rus)
D. V. Lukyantseva, O. A. Sukhorukikh, V. V. Omelyanovsky
 
Vol 5, No 2 (2012) MEDICO-ECONOMIC SUBSTANTIATION OF NORMATIVE STANDARD OF SUPPLYING STUDENTS OF MILITARY SCHOOLS WITH MEDICATIONS Abstract   PDF (Rus)
Yu. V. Miroshnichenko, V. S. Gaynov
 
Vol 9, No 2 (2016) METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY Abstract   PDF (Rus)
N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov
 
Vol 9, No 3 (2016) METHOD «COST-EFFECTIVENESS» IN EVALUETION OF ATIBIOTIC TREATMENT OF ACYTR OBSTRUCTIVE BRONCHITIS IN CHILDREN IN HOSPITAL Abstract   PDF (Rus)
O. V. Zhukova, S. V. Kononova
 
Vol 6, No 3 (2013) METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES Abstract
R. I. Yagudina, A. Ju. Kulikov, D. T. Ugrekhelidze
 
Vol 5, No 2 (2012) METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES Abstract
R. I. Yagudina, I. V. Sorokovikov
 
Vol 11, No 1 (2018) Methods of clinical assessment from the “Clinical Recommendations” resource of the Ministry of Healthcare of Russia: a systematic review Abstract   PDF (Rus)
V. M. Vatolin, O. A. Sukhorukikh, Zh. A. Galeeva, D. V. Lukyantseva, O. O. Buzuverova, O. V. Kirsanova, E. M. Murtazina, D. G. Ilyukhin, L. S. Shubina
 
Vol 7, No 3 (2014) MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN Abstract   PDF (Rus)
V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan
 
Vol 7, No 4 (2014) MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES Abstract   PDF (Rus)
M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya
 
Vol 11, No 1 (2018) Modeling microbial drug-resistance: from mathematics to pharmacoeconomics Abstract   PDF (Rus)
Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
 
Vol 11, No 4 (2018) Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease Abstract   PDF (Rus)
V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev
 
Vol 5, No 1 (2012) MODERNIZATION OF THE MEDICAL SERVICES MARKET Abstract
A. U. Kulikov
 
Vol 9, No 3 (2016) MONITORING OF CONSUMER ATTITUDES TO MEDICINES Abstract   PDF (Rus)
N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka
 
Vol 8, No 3 (2015) NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL Abstract   PDF (Rus)
D. V. Blinov
 
Vol 11, No 3 (2018) Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review Abstract   PDF (Rus)
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
 
Vol 11, No 1 (2018) Options to optimize the access to biosimilars: analysis and solutions Abstract   PDF (Rus)
O. V. Kirsanova, V. V. Omelyanovsky
 
Vol 8, No 3 (2015) ORGANIZATION AND ANALYSIS OF THE COMMISSION'S WORK ON THE SELECTION AND REFERRAL OF PATIENTS IN A MEDICAL INSTITUTION FOR TREATMENT USING ASSISTED REPRODUCTIVE TECHNOLOGIES ON THE TERRITORY OF THE CHELYABINSK REGION Abstract   PDF (Rus)
M. G. Moskvicheva, V. V. Saharova, Yu. A. Semenov, E. V. Orehova
 
Vol 11, No 4 (2018) Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense Abstract   PDF (Rus)
D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy
 
Vol 7, No 2 (2014) PARAMETERS OF HEALTH CARE SYSTEMS Abstract   PDF (Rus)
V. V. Omelyanovskiy, I. V. Maksimova, A. P. Tatarinov
 
Vol 11, No 4 (2018) Patient registers and account registries of compulsory medical insurance: integration and replaceability Abstract   PDF (Rus)
I. A. Zheleznyakova, G. I. Pirova, E. A. Proxorovich
 
Vol 7, No 1 (2014) PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY Abstract   PDF (Rus)
D. V. Blinov
 
Vol 8, No 1 (2015) PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION Abstract   PDF (Rus)
L. S. Melnikova
 
Vol 10, No 1 (2017) PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM Abstract   PDF (Rus)
N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova
 
Vol 5, No 1 (2012) PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION Abstract
R. Yagudina, A. Kulikov, B. Misikova
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia Abstract
R. I. Yagudina, I. Yu. Zinchuk
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment Abstract
A. U. Kulikov, V. V. Babiy
 
Vol 10, No 1 (2017) PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS Abstract   PDF (Rus)
A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina
 
Vol 9, No 2 (2016) PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION Abstract   PDF (Rus)
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva
 
Vol 6, No 3 (2013) PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER Abstract
R. I. Yagudina, I. Yu. Zinchuk
 
Vol 8, No 1 (2015) PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION Abstract   PDF (Rus)
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis Abstract
R. I. Yagudina, M. M. Murashko
 
Vol 6, No 3 (2013) PHARMACOECONOMIC ANALYSIS OF NEUROPROTECTIVE DRUGS IN THE TREATMENT OF ACUTE DISORDERS OF CEREBRAL CIRCULATION Abstract
A. Yu. Kulikov, I. Yu. Zinchuk
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS Abstract   PDF (Rus)
E. E. Vidyakina, S. V. Malchikova
 
Vol 7, No 3 (2014) PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA Abstract   PDF (Rus)
A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova
 
Vol 7, No 2 (2014) PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD Abstract   PDF (Rus)
A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia Abstract   PDF (Rus)
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov
 
Vol 11, No 3 (2018) Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus Abstract   PDF (Rus)
A. G. Tolkushin, N. L. Pogudina
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia Abstract   PDF (Rus)
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA Abstract   PDF (Rus)
N. A. Avxentyev, M. Yu. Frolov
 
Vol 10, No 2 (2017) PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY Abstract   PDF (Rus)
A. V. Rudakova, S. A. Protsenko, I. A. Koroleva
 
Vol 11, No 1 (2018) Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia Abstract   PDF (Rus)
I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
 
Vol 8, No 4 (2015) PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER Abstract   PDF (Rus)
D. A. Zhukov
 
Vol 10, No 2 (2017) PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA Abstract   PDF (Rus)
M. Yu. Frolov, O. V. Shatalova
 
Vol 9, No 1 (2016) PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT Abstract   PDF (Rus)
N. K. Mazina, P. V. Mazin, Yu. V. Kislitsin, E. M. Markova
 
Vol 5, No 3 (2012) PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER Abstract
A. U. Kulikov
 
Vol 5, No 1 (2012) PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION Abstract
V. G. Serpik, R. I. Yagudina
 
Vol 5, No 3 (2012) PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET Abstract
R. I. Yagudina, V. G. Serpik
 
Vol 10, No 4 (2017) PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION Abstract   PDF (Rus)
M. Yu. Frolov, V. A. Rogov
 
101 - 150 of 240 Items << < 1 2 3 4 5 > >>